CO6821935A2 - Derivados novedosos de cefalosporinas y cmposiciones farmacéuticas de estos - Google Patents

Derivados novedosos de cefalosporinas y cmposiciones farmacéuticas de estos

Info

Publication number
CO6821935A2
CO6821935A2 CO13229094A CO13229094A CO6821935A2 CO 6821935 A2 CO6821935 A2 CO 6821935A2 CO 13229094 A CO13229094 A CO 13229094A CO 13229094 A CO13229094 A CO 13229094A CO 6821935 A2 CO6821935 A2 CO 6821935A2
Authority
CO
Colombia
Prior art keywords
cmpositions
pharmaceutical
cephalosporin derivatives
novel cephalosporin
novel
Prior art date
Application number
CO13229094A
Other languages
English (en)
Inventor
Young Lag Cho
Joung Yul Yun
Chul Soon Park
Sang Eun Chae
Hyang Sook Lee
Kyuman Oh
Hye Jin Heo
Dae Hyuck Kang
Young Jae Yang
Hyun Jin Kwon
Tae Kyo Park
Sung Ho Woo
Yong Zu Kim
Original Assignee
Legochem Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Legochem Biosciences Inc filed Critical Legochem Biosciences Inc
Publication of CO6821935A2 publication Critical patent/CO6821935A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/60Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 3 and 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La presente invención se refiere a derivaos novedosos de cefalosporinas representados por la fórmula química 1.
CO13229094A 2011-03-30 2013-09-26 Derivados novedosos de cefalosporinas y cmposiciones farmacéuticas de estos CO6821935A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020110028603A KR101719556B1 (ko) 2011-03-30 2011-03-30 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물

Publications (1)

Publication Number Publication Date
CO6821935A2 true CO6821935A2 (es) 2013-12-31

Family

ID=46932135

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13229094A CO6821935A2 (es) 2011-03-30 2013-09-26 Derivados novedosos de cefalosporinas y cmposiciones farmacéuticas de estos

Country Status (27)

Country Link
US (2) US8329684B2 (es)
EP (1) EP2706062B1 (es)
JP (1) JP6144669B2 (es)
KR (1) KR101719556B1 (es)
CN (1) CN103547583B (es)
AU (1) AU2012237063B2 (es)
BR (1) BR112013025275A2 (es)
CA (1) CA2831421C (es)
CL (1) CL2013002820A1 (es)
CO (1) CO6821935A2 (es)
CR (1) CR20130501A (es)
CU (1) CU20130125A7 (es)
DK (1) DK2706062T3 (es)
DO (1) DOP2013000214A (es)
EA (1) EA024709B1 (es)
ES (1) ES2683351T3 (es)
HR (1) HRP20181170T1 (es)
HU (1) HUE039086T2 (es)
IL (1) IL228408A (es)
LT (1) LT2706062T (es)
MX (1) MX359435B (es)
PL (1) PL2706062T3 (es)
PT (1) PT2706062T (es)
SG (1) SG193998A1 (es)
SI (1) SI2706062T1 (es)
WO (1) WO2012134184A2 (es)
ZA (1) ZA201308078B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883772B2 (en) 2007-10-09 2014-11-11 Sopharmia, Inc. Broad spectrum beta-lactamase inhibitors
US10844064B2 (en) 2014-09-17 2020-11-24 Cyclerion Therapeutics, Inc. sGC stimulators
US10059680B2 (en) * 2014-12-18 2018-08-28 Merck Sharp & Dohme Corp. Thiadiazolyl-oximinoacetic acid derivative compounds
US20160176897A1 (en) 2014-12-23 2016-06-23 Merck Sharp & Dohme Corp. 7-aminocephem derivative compounds
BR112018009725A8 (pt) 2015-12-10 2019-02-26 Naeja Rgm Pharmaceuticals Ulc compostos de cefém, sua produção e uso
CN109843896B (zh) * 2016-10-14 2022-12-20 波尔图大学 羟基肉桂酸衍生物、方法及其用途
KR20180093307A (ko) * 2017-02-13 2018-08-22 주식회사 레고켐 바이오사이언스 4, 5-디아미노 치환 피리미딘 유도체의 제조방법 및 이를 제조하기 위한 신규한 화합물
WO2019145784A2 (en) * 2018-01-26 2019-08-01 Legochem Biosciences, Inc. Combination therapies for multi-drug resistant pathogens
CN109762791B (zh) * 2018-11-19 2021-02-09 厦门联合安金生物工程有限公司 包含BPI-Fc嵌合基因的重组腺病毒及其用途
CN111471058A (zh) * 2019-01-23 2020-07-31 中国医学科学院药物研究所 用于制备头孢吡普类似物的方法
WO2021043973A1 (en) 2019-09-06 2021-03-11 Nabriva Therapeutics GmbH Siderophore cephalosporin conjugates and uses thereof
CN111635377A (zh) * 2020-06-30 2020-09-08 南京红杉生物科技有限公司 噻二唑类化合物及其合成方法
WO2022235077A1 (ko) * 2021-05-07 2022-11-10 한국생명공학연구원 신규 사이드로포어 화합물 및 이를 이용한 금속 나노입자 복합체

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
EP0303172A3 (de) * 1987-08-14 1991-05-15 F. Hoffmann-La Roche Ag Oxyimino-Cephalosporine
GB8817653D0 (en) * 1988-07-25 1988-09-01 Fujisawa Pharmaceutical Co New cephem compounds & processes for preparation thereof
GB9111406D0 (en) * 1991-05-28 1991-07-17 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
US5498777A (en) * 1994-07-20 1996-03-12 Merck & Co., Inc. 3-thioheteroaryl cephalosporin compounds, compositions and methods of use
TW200305422A (en) * 2002-03-18 2003-11-01 Shionogi & Co Broad spectrum cefem compounds
DE602004012269T2 (de) * 2003-07-11 2009-04-30 Theravance, Inc., South San Francisco Quervernetzte glycopeptid-cephalosporin-antibiotika
AU2005219718A1 (en) * 2004-03-05 2005-09-15 Shionogi & Co., Ltd. 3-pyridinium methylcephem compound
AU2005202802A1 (en) * 2004-06-28 2006-01-12 Astellas Pharma Inc. Cephem compounds
CN101230070A (zh) * 2006-12-30 2008-07-30 黄振华 新型抗感染头孢类化合物
CA2736953C (en) * 2008-10-31 2017-07-11 Shionogi & Co., Ltd. Cephalosporins having catechol group

Also Published As

Publication number Publication date
LT2706062T (lt) 2018-10-25
CN103547583A (zh) 2014-01-29
CN103547583B (zh) 2016-11-16
AU2012237063A1 (en) 2013-10-17
CU20130125A7 (es) 2014-03-26
JP6144669B2 (ja) 2017-06-07
EA024709B1 (ru) 2016-10-31
CA2831421A1 (en) 2012-10-04
BR112013025275A2 (pt) 2016-12-13
HRP20181170T1 (hr) 2018-11-02
WO2012134184A3 (ko) 2013-03-07
DOP2013000214A (es) 2013-12-15
MX2013010961A (es) 2014-03-27
US9630977B2 (en) 2017-04-25
ZA201308078B (en) 2019-01-30
JP2014510750A (ja) 2014-05-01
SI2706062T1 (sl) 2018-11-30
ES2683351T3 (es) 2018-09-26
EP2706062A4 (en) 2015-01-21
IL228408A (en) 2017-01-31
CL2013002820A1 (es) 2014-04-11
MX359435B (es) 2018-09-28
KR20120110625A (ko) 2012-10-10
SG193998A1 (en) 2013-11-29
US20120264727A1 (en) 2012-10-18
EP2706062B1 (en) 2018-05-09
CR20130501A (es) 2014-05-13
DK2706062T3 (en) 2018-08-06
IL228408A0 (en) 2013-12-31
PT2706062T (pt) 2018-09-28
HUE039086T2 (hu) 2018-12-28
EP2706062A2 (en) 2014-03-12
CA2831421C (en) 2019-06-04
KR101719556B1 (ko) 2017-03-24
US8329684B2 (en) 2012-12-11
AU2012237063B2 (en) 2017-03-16
WO2012134184A2 (ko) 2012-10-04
EA201391325A1 (ru) 2014-04-30
PL2706062T3 (pl) 2018-11-30
WO2012134184A8 (ko) 2013-10-24
US20130178455A1 (en) 2013-07-11

Similar Documents

Publication Publication Date Title
CO6821935A2 (es) Derivados novedosos de cefalosporinas y cmposiciones farmacéuticas de estos
CY1119105T1 (el) Παραγωγα διπυραζολιου ως αναστολεις jak
CR20130369A (es) Novedosos derivados heterocíclicos
CR20140510A (es) Nucleósidos de espirooxetano de uracilo
UY34825A (es) Síntesis de compuestos heterocíclicos
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
CR20130045A (es) Compuestos terapéuticos
CR20150418A (es) Compuestos de tetrahidropirrolotiazina
CR20130470A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO [2,3-d]PIRIMIDINA TROMPOMIOSINA
CR20140132A (es) Derivados de pirrolopirimidina y purina
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
CR20130419A (es) Derivados heterocíclicos de amina
CR20130539A (es) Triazolopiridinas
RS54730B1 (sr) Inhibitori beta sekretaze
CR20120297A (es) Espironucleósidos uracílicos oxetánicos
CR20120637A (es) Triazolopiridinas sustituidas
CR20150084A (es) 2-oxo-2,3-dihidro-indoles
CR20140306A (es) Fluormetil -5,6-dihidro-4h-[1,3] oxazinas
MX364069B (es) Moduladores de la proteína activadora de 5-lipoxigenasa.
MA33948B1 (fr) Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques.
CR20140322A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
CR20140495A (es) 5-amino[1,4]thiazines como inhibidores de bace1
UA113086C2 (xx) Піразольні сполуки як інгібітори sglt1
IN2014KN01062A (es)
EA201101675A1 (ru) Спироэпоксиды как промежуточные продукты синтеза

Legal Events

Date Code Title Description
FA Application withdrawn